References
- 1. TANASE A., TOMULEASA C., MARCULESCU A., BARDAS A., COLITA A, ORBAN C., et al., Haploidentical donors: can faster transplantation be life-saving for patients with advanceddisease? Acta Haematol. 2016; 135(4):211-6.
- 2. BRAMMER J.E., KHOURI I., GABALLA S., ANDERLINI P., TOMULEASA C., AHMED S., et al., Outcomes of haploidentical stem cell transplantation for lymphoma with melphalan-based conditioning. Biol Blood Marrow Transplant. 2016; 22(3):493-8.
- 3. PAGANO L., CAIRA M., CANDONI A., OFFIDANI M., FIANCHI L., MARTINO B., et al., The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068.
- 4. CHAMILOS G., LUNA M., LEWIS R.E., BODEY G.P., CHEMALY R., TARRAND J.J., et al., Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91:986.
- 5. HACHEM R., HANNA H., KONTOYIANNIS D., JIANG Y., RAAD I., The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008; 112:2493.
- 6. CORNELY O.A., GACHOT B., AKAN H., BASSETTI M., UZUN O., KIBBLER C., et al., Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis 2015; 61:324.
- 7. PAGANO L., AKOVA M., DIMOPOULOS G., HERBRECHT R., DRGONA L., BLIJLEVENS N., Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011; 66 Suppl 1:i5.
- 8. FREIFIELD A.G., BOW E.J., SEPKOWITZ K.A., BOECKH M.J., ITO J.I., MULLEN C.A., et al., Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011; 52:e56.
- 9. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Prevention and treatment of cancer-related infections. Version 2. 2014. http://www.nccn.org (Accessed on July 24, 2016).
- 10. MAERTENS J., MARCHETTI O., HERBRECHT R., CORNELY O.A., FLUCKIGER U., FRERE P. et al., European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update. Bone Marrow Transplant 2011; 46:709.
- 11. CORNELY O.A., BOHME A., BUCHHEIDT D., EINSELE H., HEINZ W.J., KARTHAUS M., et al., Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica 2009; 94:113.
- 12. SEGAL B.H., FREIFIELD A.G., BADEN L.R., BROWN A.E., CASPER C., DUBBERKE E., GELFAND M., et al., Prevention and treatment of cancer-related infections. J Natl Compr Cancer Netw 2008, 6(2):122-174.
- 13. CICHRA A., MAKARYUS M., CHAUDHRI P., NARASIMHAN M., Ultrasound for the pulmonary consultant. Clin Med Insights Circ Respir Pulm Med. 2016; 10:1-9.
- 14. SPERANDEO M., FILABOZZI P., VARRIALE A., CARNEVALE V., PIATELLI M.L., SPERANDEO G., et al., Role of thoracic ultrasound in the assessment of pleural and pulmonary diseases. J Ultrasound. 2008; 11(2):39-46.
- 15. DOHNER H., WEISDORF D.J., BLOOMFIELD C.D., Acute myeloid leukemia. N Engl J Med. 2015; 373(12):1136-52.
- 16. FISCHER R.I., GAYNOR E.R., DAHLBERG S., OKEN M.M., GROGAN T.M., MIZE E.M., et al., Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993; 328(14):1002-6.
- 17. JAGANNATH S., DURIE B.G., WOLF J., CAMACHO E., IRWIN D., LUTZKY J., et al., Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma. Br J Haematol. 2005; 129(6):776-83.